Fractional CO2 Laser Therapy Systems,FG900 - Dermatological carbon dioxide laser system
Access comprehensive regulatory information for Fractional CO2 Laser Therapy Systems,FG900 - Dermatological carbon dioxide laser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Compliance Management Solutions, manufactured by Beijing ADSS Development Co Ltd in China. The device registration started on September 27, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
The Fractional CO2 Laser Therapy Systems is indicated for treatment of skin diseases, including Seborrheic keratosis, Syringoma, Verruca vulgaris, Flat wart, Eyelid xanthoma, Melanocytic nevus.